On Friday, the U.S. Food and Drug Administration (FDA) approved Cymbalta (duloxetine hydrochloride) for use as a treatment for chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain.
View original post here:
FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain – HealthNews
